Fish oil and vascular endothelial protection: Bench to bedside

Free Radical Biology and Medicine

Volumn 53, Issue 2, 2012, Pages 271-279

  Balakumar, Pitchai ^a   Taneja, Gaurav ^a  

^a Rajendra Institute of Technology and Sciences   (India)

Author keywords

3 PUFA; Cardiovascular disorders; EDRF; eNOS; Fish oil; Free radicals; Vascular endothelial dysfunction

Indexed keywords

CAVEOLIN; CAVEOLIN 1; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FISH OIL; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 90; ICOSAPENTAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OMEGA 3 FATTY ACID; PLACEBO; PROSTANOID; PROTEIN KINASE B; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SERINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART FAILURE; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MEDIATOR; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR ENDOTHELIAL DYSFUNCTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FISH OILS; HUMANS; HYPERTRIGLYCERIDEMIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; UP-REGULATION;

EID: 84862296791     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.05.005     Document Type: Review

References (132)

1. P.C. Calder n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored Clin. Sci. (London) 107 2004 1 11 (Pubitemid 38932191)
2. M.L. Burr, A.M. Fehily, J.F. Gilbert, S. Rogers, R.M. Holliday, P.M. Sweetnam, P.C. Elwood, and N.M. Deadman Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 2 1989 757 761 (Pubitemid 19234807)
3. Lancet 354 1999 447 455
4. M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, T. Kita, A. Kitabatake, N. Nakaya, T. Sakata, K. Shimada, K. Shirato, and E.P.A. Japan Lipid Intervention Study investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098 (Pubitemid 46483662)
5. J.H. Lee, J.H. OKeefe, C.J. Lavie, R. Marchioli, and W.S. Harris Omega-3 fatty acids for cardioprotection Mayo Clin. Proc. 83 2008 324 332 (Pubitemid 351469243)
6. C.J. Lavie, R.V. Milani, M.R. Mehra, and H.O. Ventura Omega-3 polyunsaturated fatty acids and cardiovascular diseases J. Am. Coll. Cardiol. 54 2009 585 594
7. D. Moertl, A. Hammer, S. Steiner, R. Hutuleac, K. Vonbank, and R. Berger Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study Am. Heart J 161 915.e1-9 2011
8. M. Sagara, M. Njelekela, T. Teramoto, T. Taguchi, M. Mori, L. Armitage, N. Birt, C. Birt, and Y. Yamori Effects of docosahexaenoic acid supplementation on blood pressure, heart rate, and serum lipids in Scottish men with hypertension and hypercholesterolemia Int. J. Hypertens. 2011 2011 809198
9. P. Angerer, W. Kothny, S. Störk, and C. von Schacky Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries Cardiovasc. Res 54 2002 183 190 (Pubitemid 34327948)
10. E.M. Hjerkinn, M. Abdelnoor, L. Breivik, L. Bergengen, I. Ellingsen, I. Seljeflot, O. Aase, T. Ole Klemsdal, I. Hjermann, and H. Arnesen Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia Eur. J. Cardiovasc. Prev. Rehabil. 13 2006 325 333 (Pubitemid 44318641)
11. T.A. Mori Omega-3 fatty acids and blood pressure Cell. Mol. Biol. (Noisy-le-grand) 56 2010 83 92
12. L.J. Schwellenbach, K.L. Olson, K.J. McConnell, R.S. Stolcpart, J.D. Nash, J.A. Merenich, and Clinical Pharmacy Cardiac Risk Service Study Group The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides J. Am. Coll. Nutr 25 2006 480 485 (Pubitemid 46175663)
13. P.G. Swann, D.L. Venton, and G.C. Le Breton Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets FEBS Lett 243 1989 244 246 (Pubitemid 19037485)
14. D.C. Gaudette, and B.J. Holub Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity Lipids 25 1990 166 169 (Pubitemid 20140046)
15. M.F. Chen, H.C. Hsu, W.J. Chen, C.M. Lee, C.C. Wu, C.S. Liau, and Y.T. Lee Fish oil supplementation attenuates free radical generation in short-term coronary occlusion-reperfusion in cholesterol-fed rabbits Prostaglandins 47 1994 307 317
16. M. Massaro, A. Habib, L. Lubrano, S. Del Turco, G. Lazzerini, T. Bourcier, B.B. Weksler, and R. De Caterina The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition Proc. Natl. Acad. Sci. USA 103 2006 15184 15189 (Pubitemid 44583185)
17. M.V. Pchelintsev Clinico-pharmacological effects of eicosapentaenoic and docosahexaenoic (omega-3) acids in the treatment of ischemic heart disease and prevention of sudden cardiac death from position of evidence based medicine Kardiologiia 50 2010 74 78
18. Davignon, J.; Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation 109:III27-III32; 2004. (Pubitemid 38786440)
19. S. Sitia, L. Tomasoni, F. Atzeni, G. Ambrosio, C. Cordiano, A. Catapano, S. Tramontana, F. Perticone, P. Naccarato, P. Camici, E. Picano, L. Cortigiani, M. Bevilacqua, L. Milazzo, D. Cusi, C. Barlassina, P. Sarzi-Puttini, and M. Turiel From endothelial dysfunction to atherosclerosis Autoimmun. Rev. 9 2010 830 834
20. P. Puddu, G.M. Puddu, F. Zaca, and A. Muscari Endothelial dysfunction in hypertension Acta Cardiol. 55 2000 221 232
21. G.S. Sainani, and V.G. Maru Role of endothelial cell dysfunction in essential hypertension J. Assoc. Physicians India 52 2004 966 969 (Pubitemid 41279959)
22. V.H. Lyzohub, O.V. Savchenko, O.M. Bondarchuk, I.S. Dykukha, O.O. Voloshyna, T.V. Bohdan, S.M. Kovalchuk, and IuO Moshkovska Connection of endothelial dysfunction and level of blood leukocytes with clinical course of stable angina pectoris in patients with ischemic heart disease Lik. Sprava 1-2 2008 67 71
23. S. Ulker, P.P. McKeown, and U. Bayraktutan Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities Hypertension 41 2003 534 539 (Pubitemid 36314628)
24. E. Schulz, T. Jansen, P. Wenzel, A. Daiber, and T. Münzel Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension Antioxid. Redox Signaling 10 2008 1115 1126 (Pubitemid 351451710)
25. P. Balakumar, T. Kaur, and M. Singh Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions Toxicology 245 2008 49 64
26. P. Balakumar, V.A. Chakkarwar, P. Krishan, and M. Singh Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed. Pharmacother. 63 2009 171 179
27. J. Kaur, K. Reddy, and P. Balakumar The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat Cardiovasc. Toxicol 10 2010 227 238
28. M. Omura, S. Kobayashi, Y. Mizukami, K. Mogami, N. Todoroki-Ikeda, T. Miyake, and M. Matsuzaki Eicosapentaenoic acid (EPA) induced Ca(2)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation FEBS Lett 487 2001 361 366 (Pubitemid 32121757)
29. D. López, X. Orta, K. Casós, M.P. Sáiz, P. Puig-Parellada, M. Farriol, and M.T. Mitjavila Upregulation of endothelial nitric oxide synthase in rat aorta after ingestion of fish oil-rich diet Am. J. Physiol. Heart Circ. Physiol 287 2004 H567 572
30. M.D. Nyby, K. Matsumoto, K. Yamamoto, K. Abedi, P. Eslami, G. Hernandez, V. Smutko, M.E. Berger, and M.L. Tuck Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats Am. J. Hypertens. 18 2005 213 219 (Pubitemid 40332551)
31. Q. Li, Q. Zhang, M. Wang, S. Zhao, J. Ma, N. Luo, N. Li, Y. Li, G. Xu, and J. Li Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase Biochimie 89 2007 169 177 (Pubitemid 44959288)
32. W.C. Aird Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms Circ. Res. 100 2007 158 173 (Pubitemid 46208717)
33. R. Busse, and E. Bassenge Regulation of vascular tone by the endothelium Z. Kardiol. 74 1985 99 106
34. S. Itoh, and T. Ohashi Role of vascular endothelial cells in vasoconstriction and vasodilation Nihon Heikatsukin Gakkai Zasshi 21 1985 272 274
35. E. Bassenge Endothelial function in different organs Prog. Cardiovasc. Dis. 39 1996 209 228 (Pubitemid 26424608)
36. M. Cucuianu The role of the endothelia in hemostasis Rev. Med. Chir. Soc. Med. Nat. Iasi. 100 1996 17 25
37. D.B. Cines, E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, R.P. McEver, J.S. Pober, T.M. Wick, B.A. Konkle, B.S. Schwartz, E.S. Barnathan, K.R. McCrae, B.A. Hug, A.M. Schmidt, and D.M. Stern Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561 (Pubitemid 28225719)
38. F. Desjardins, and J.L. Balligand Nitric oxide-dependent endothelial function and cardiovascular disease Acta Clin. Belg. 61 2006 326 334
39. E.I. Babiluri Endothelium-dependent vascular smooth muscle relaxation and contraction. Georgian Med News 167 2009 89 92
40. V.W. van Hinsbergh Endothelium - role in regulation of coagulation and inflammation Semin. Immunopathol. 34 2011 93 106
41. T.F. Lüscher Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels Lung 168 1990 27 34 (Pubitemid 20217629)
42. J.P. Tolins, P.J. Shultz, and L. Raij Role of endothelium-derived relaxing factor in regulation of vascular tone and remodeling: update on humoral regulation of vascular tone Hypertension 17 1991 909 916
43. D.D. Wagner, and R. Bonfanti von Willebrand factor and the endothelium Mayo Clin. Proc. 66 1991 621 627
44. R.F. Furchgott, and P.M. Vanhoutte Endothelium-derived relaxing and contracting factors FASEB J 3 1989 2007 2018 (Pubitemid 19187609)
45. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376 (Pubitemid 11169009)
46. R.F. Furchgott Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide P.M. Van Houtte, Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium 1988 Raven Press New York 401 414
47. L.J. Ignarro, R.E. Byrns, and K.S. Wood Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical P.M. Van Houtte, Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium 1988 Raven Press New York 401 414
48. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526 (Pubitemid 17085822)
49. P.J. Andrew, and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc. Res. 43 1999 521 531 (Pubitemid 29369251)
50. I. Fleming, and R. Busse Signal transduction of eNOS activation Cardiovasc. Res. 43 1999 532 541 (Pubitemid 29369252)
51. J.V. Mombouli, and P.M. Vanhoutte Endothelial dysfunction: from physiology to therapy J. Mol. Cell. Cardiol. 31 1999 61 74 (Pubitemid 29078219)
52. G.Y. Lip, A.D. Blann, J. Zarifis, M. Beevers, P.L. Lip, and D.G. Beevers Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report J. Hypertens. 13 1995 1674 1678 (Pubitemid 26015796)
53. P. Poredos Endothelial dysfunction in the pathogenesis of atherosclerosis Clin. Appl. Thromb. Hemostasis 7 2001 276 280 (Pubitemid 32988889)
54. J.B. Laursen, S. Boesgaard, S. Trautner, I. Rubin, H.E. Poulsen, and J. Aldershvile Endothelium-dependent vasorelaxation is inhibited by in vivo depletion of vascular thiol levels: role of endothelial nitric oxide synthase Free Radic. Res. 35 2001 387 394 (Pubitemid 32894357)
55. J.W. Rush, S.G. Denniss, and D.A. Graham Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity Can. J. Appl. Physiol. 30 2005 442 474
56. P. Balakumar, R. Sharma, and M. Singh Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat Pharmacol. Res. 58 2008 356 363
57. P. Balakumar, V.A. Chakkarwar, and M. Singh Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat Mol. Cell. Biochem 320 2009 149 162
58. A.C. Montezano, and R.M. Touyz Reactive oxygen species and endothelial function - role of NOS uncoupling and Nox family NADPH oxidases Basic Clin. Pharmacol. Toxicol. 110 2011 87 94
59. K.M. Naseem The role of nitric oxide in cardiovascular diseases Mol. Aspects Med. 26 2005 33 65 (Pubitemid 40250164)
60. T.F. Lüscher, Z.H. Yang, D. Diederich, and F.R. Bühler Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion J. Cardiovasc. Pharmacol. 14 1989 S63 69
61. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
62. P.J. Kuhlencordt, R. Gyurko, F. Han, M. Scherrer-Crosbie, T.H. Aretz, R. Hajjar, and M.H. Picard Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454 (Pubitemid 32678276)
63. R. Xia, B. Zhao, Y. Wu, J.B. Hou, L. Zhang, J.J. Xu, and Z.Y. Xia Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats J. Biomed. Biotechnol. 2011 767930 2011
64. S.P. Jones, J.J. Greer, R. van Haperen, D.J. Duncker, R. de Crom, and D.J. Lefer Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice Proc. Natl. Acad. Sci. USA 100 2003 4891 4896 (Pubitemid 36457824)
65. A. Schäfer, D. Fraccarollo, S. Pförtsch, E. Loch, J. Neuser, C. Vogt, and J. Bauersachs Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure Basic Res. Cardiol. 106 2011 485 494
66. P.M. Kris-Etherton, W.S. Harris, L.J. Appel, and American Heart Association Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757 (Pubitemid 35364932)
67. C. Wang, W.S. Harris, M. Chung, A.H. Lichtenstein, E.M. Balk, B. Kupelnick, H.S. Jordan, and J. Lau n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clin. Nutr. 84 2006 5 17 (Pubitemid 44699166)
68. N.I.H. Medline Plus 2008. 〈http://www.nlm.nih.gov/medlineplus/ druginfo/natural/patient-fishoil.html〉. Accessed on 31 July 2011.
69. D.L. Lawson, J.L. Mehta, K. Saldeen, P. Mehta, and T.G. Saldeen Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins Eicosanoids 4 1991 217 223
70. D. Fontaine, A. Otto, L. Portois, J. Fontaine, G. Berkenboom, W.J. Malaisse, and Y.A. Carpentier Protection of aortic endothelial function in both normal and diabetic rats by intravenous bolus injection of a medium-chain triglyceride: fish oil emulsion Int. J. Mol. Med. 18 2006 697 704
71. K. Toutouzas, M. Riga, E. Stefanadi, and C. Stefanadis Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance Horm. Metab. Res. 40 2008 655 659
72. L. Sibal, S.C. Agarwal, P.D. Home, and R.H. Boger The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease Curr. Cardiol. Rev. 6 2010 82 90
73. L. Raimondi, M. Lodovici, F. Visioli, L. Sartiani, L. Cioni, C. Alfarano, G. Banchelli, R. Pirisino, E. Cecchi, E. Cerbai, and A. Mugelli n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats Eur. J. Nutr. 44 2005 327 333 (Pubitemid 41285601)
74. K. Casós, M.C. Zaragozá, N. Zarkovic, K. Zarkovic, L. Andrisic, M. Portero-Otín, D. Cacabelos, and M.T. Mitjavila A fish-oil-rich diet reduces vascular oxidative stress in apoE(-/-) mice Free Radic. Res. 44 2010 821 829
75. T. Matsumoto, N. Nakayama, K. Ishida, T. Kobayashi, and K. Kamata Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes J. Pharmacol. Exp. Ther 329 2009 324 334
76. T.M. Wang, C.J. Chen, T.S. Lee, H.Y. Chao, W.H. Wu, S.C. Hsieh, H.H. Sheu, and A.N. Chiang Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells J. Nutr. Biochem. 22 2011 187 194
77. H. Kurihara, M. Yoshizumi, T. Sugiyama, K. Yamaoki, R. Nagai, F. Takaku, H. Satoh, J. Inui, M. Yanagisawa, and T. Masaki The possible role of endothelin-1 in the pathogenesis of coronary vasospasm J. Cardiovasc. Pharmacol. 13 1989 S132 137
78. K. Chisaki, Y. Okuda, S. Suzuki, T. Miyauchi, M. Soma, N. Ohkoshi, H. Sone, N. Yamada, and T. Nakajima Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells Hypertens. Res. 26 2003 655 661 (Pubitemid 37080798)
79. K. Yin, Z.M. Chu, and L.J. Beilin Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils Br. J. Pharmacol. 106 1992 435 442
80. S. Cayli, L. Sati, Y. Seval-Celik, M.A. Tuncer, B. Yaymaci, Z. Berkman, T. Altug, and R. Demir The effects of eicosapentaenoic acid on the endothelium of the carotid artery of rabbits on a high-cholesterol diet Histol. Histopathol. 25 2010 141 151
81. H. Tagawa, H. Shimokawa, T. Tagawa, M. Kuroiwa-Matsumoto, Y. Hirooka, and A. Takeshita Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease J. Cardiovasc. Pharmacol 33 1999 633 640 (Pubitemid 29164828)
82. J.P. Chin, and A.M. Dart Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils Clin. Exp. Pharmacol. Physiol. 21 1994 749 755 (Pubitemid 24348654)
83. G.E. McVeigh, G.M. Brennan, G.D. Johnston, B.J. McDermott, L.T. McGrath, W.R. Henry, J.W. Andrews, and J.R. Hayes Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 36 1993 33 38 (Pubitemid 23018332)
84. G.K. Goode, S. Garcia, and A.M. Heagerty Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study Circulation 96 1997 2802 2807 (Pubitemid 27500074)
85. J. Goodfellow, M.F. Bellamy, M.W. Ramsey, C.J. Jones, and M.J. Lewis Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia J. Am. Coll. Cardiol. 35 2000 265 270 (Pubitemid 30125512)
86. W. Kothny, P. Angerer, S. Stork, and C. von Schacky Short term effects of omega-3 fatty acids on the radial artery of patients with coronary artery disease Atherosclerosis 140 1998 181 186 (Pubitemid 28378469)
87. C.A. Fahs, H. Yan, S. Ranadive, L.M. Rossow, S. Agiovlasitis, K.R. Wilund, and B. Fernhall The effect of acute fish-oil supplementation on endothelial function and arterial stiffness following a high-fat meal Appl. Physiol. Nutr. Metab. 35 2010 294 302
88. T.A. Mori, G.F. Watts, V. Burke, E. Hilme, I.B. Puddey, and L.J. Beilin Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men Circulation 102 2000 1264 1269
89. D.R. Morgan, L.J. Dixon, C.G. Hanratty, N. El-Sherbeeny, P.B. Hamilton, L.T. McGrath, W.J. Leahey, G.D. Johnston, and G.E. McVeigh Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure Am. J. Cardiol. 97 2006 547 551 (Pubitemid 43190048)
90. G. Ren, O. Dewald, and N.G. Frangogiannis Inflammatory mechanisms in myocardial infarction Curr. Drug Targets Inflammation Allergy 2 2003 242 256
91. P. Balakumar, and M. Singh Anti-tumour necrosis factor-alpha therapy in heart failure: future directions Basic Clin. Pharmacol. Toxicol. 99 2006 391 397 (Pubitemid 44813905)
92. A.P. Davel, M. Lemos, L.M. Pastro, S.C. Pedro, P.A. de André, C. Hebeda, S.H. Farsky, P.H. Saldiva, and L.V. Rossoni Endothelial dysfunction in the pulmonary artery induced by concentrated fine particulate matter exposure is associated with local but not systemic inflammation Toxicology 295 2012 39 46
93. T. Usui, M. Okada, W. Mizuno, M. Oda, N. Ide, T. Morita, and Y. Hara Yamawaki, H. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats Am. J. Physiol. Heart Circ. Physiol 302 2012 H1894 1904
94. H. Chen, D. Li, J. Chen, G.J. Roberts, T. Saldeen, J.L. Mehta, and D.H.A. EPA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway J. Mol. Cell. Cardiol. 35 2003 769 775 (Pubitemid 36773589)
95. M. Massaro, E. Scoditti, M.A. Carluccio, M.C. Campana, and R. De Caterina Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils Cell. Mol. Biol. (Noisy-le-grand) 56 2010 59 82
96. S.M. Prescott The effect of eicosapentaenoic acid on leukotriene B production by human neutrophils J. Biol. Chem 259 1984 7615 7621 (Pubitemid 14081170)
97. E.J. Corey, C. Shih, and J.R. Cashman Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis Proc. Natl. Acad. Sci. USA 80 1983 3581 3584 (Pubitemid 13063121)
98. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037 (Pubitemid 35231761)
99. C.N. Serhan, K. Gotlinger, S. Hong, and M. Arita Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis Prostaglandins Other Lipid Mediators 73 2004 155 172 (Pubitemid 38757795)
100. M. Arita, T. Ohira, Y.P. Sun, S. Elangovan, N. Chiang, and C.N. Serhan Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation J. Immunol. 178 2007 3912 3917 (Pubitemid 46417661)
101. S. Hong, K. Gronert., P.R. Devchand, R.L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autacoids in anti-inflammation J. Biol. Chem. 278 2003 14677 14687 (Pubitemid 36799790)
102. P. Kohli, and B.D. Levy Resolvins and protectins: mediating solutions to inflammation Br. J. Pharmacol. 158 2009 960 971
103. M. Spite, L.V. Norling, L. Summers, R. Yang, D. Cooper, N.A. Petasis, R.J. Flower, M. Perretti, and C.N. Serhan Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
104. M. Dona, G. Fredman, J.M. Schwab, N. Chiang, M. Arita, A. Goodarzi, G. Cheng, U.H. von Andrian, and C.N. Serhan Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets Blood 112 2008 848 855
105. K.T. Keyes, Y. Ye, Y. Lin, C. Zhang, J.R. Perez-Polo, P. Gjorstrup, and Y. Birnbaum Resolvin E1 protects the rat heart against reperfusion injury Am. J. Physiol. Heart Circ. Physiol 299 2010 H153 164
106. M. Taura, K. Miyano, R. Minakami, S. Kamakura, R. Takeya, and H. Sumimoto A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in activation of the phagocyte NADPH oxidase Biochem. J. 419 2009 329 338
107. P. Balakumar, M.K. Arora, J. Reddy, and M.B. Anand-Srivastava Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism J. Cardiovasc. Pharmacol. 54 2009 129 138
108. D. Richard, C. Wolf, U. Barbe, K. Kefi, P. Bausero, and F. Visioli Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway Biochem. Biophys. Res. Commun. 389 2009 516 522
109. L.Y. Chen, R. Jokela, D.Y. Li, A.A. Bavry, H. Sandler, M. Sjöquist, T. Saldeen, and J.L. Mehta Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and superoxide dismutase activity J. Cardiovasc. Pharmacol. 35 2000 502 505 (Pubitemid 30127200)
110. H. Erdogan, E. Fadillioglu, S. Ozgocmen, S. Sogut, B. Ozyurt, O. Akyol, and O. Ardicoglu Effect of fish oil supplementation on plasma oxidant/antioxidant status in rats. Prostaglandins Leukotrienes Essent Fatty Acids 71 2004 149 152 (Pubitemid 38903059)
111. R. Gyurko, P. Kuhlencordt, M.C. Fishman, and P.L. Huang Modulation of mouse cardiac function in vivo by eNOS and ANP Am. J. Physiol. Heart Circ. Physiol 278 2000 971 981
112. P. Balakumar, S. Kathuria, G. Taneja, S. Kalra, and N. Mahadevan Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? J. Mol. Cell. Cardiol. 52 2012 83 92
113. P.F. Mount, B.E. Kemp, and D.A. Power Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation J. Mol. Cell. Cardiol. 42 2007 271 279 (Pubitemid 46135596)
114. W.C. Sessa Regulation of endothelial derived nitric oxide in health and disease Mem. Inst. Oswaldo Cruz 100 2005 15 18 (Pubitemid 40685434)
115. H. Ju, R. Zou, V.J. Venema, and R.C. Venema Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity J. Biol. Chem. 272 1997 18522 18525 (Pubitemid 27318186)
116. B. Razani, S.E. Woodman, and M.P. Lisanti Caveolae: from cell biology to animal physiology Pharmacol. Rev. 54 2002 431 467
117. J.B. Michel, O. Feron, K. Sase, P. Prabhakar, and T. Michel Caveolin versus calmodulin: counterbalancing allosteric modulators of endothelial nitric oxide synthase J. Biol. Chem. 272 1997 25907 25912 (Pubitemid 27438916)
118. Q. Li, Q. Zhang, M. Wang, F. Liu, S. Zhao, J. Ma, N. Luo, N. Li, Y. Li, G. Xu, and J. Li Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae Arch. Biochem. Biophys. 466 2007 250 259 (Pubitemid 47451343)
119. G. Garcia-Cardena, R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W.C. Sessa Dynamic activation of endothelial nitric oxide synthase by Hsp90 Nature 392 1998 821 824 (Pubitemid 28225323)
120. J.P. Gratton, J. Fontana, D.S. O'Connor, G. Garcia-Cardena, T.J. McCabe, and W.C. Sessa Reconstitution of an endothelial nitric oxide synthase, hsp90 and caveolin-1 complex in vitro: evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1 J. Biol. Chem. 275 2000 22268 22272 (Pubitemid 30621809)
121. S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse, and A.M. Zeiher Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation Nature 399 1999 601 605
122. J. Fontana, D. Fulton, Y. Chen, T.A. Fairchild, T.J. McCabe, N. Fujita, T. Tsuruo, and W.C. Sessa Domain mapping studies reveal that the m domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release Circ. Res. 90 2002 866 873 (Pubitemid 34633878)
123. S. Takahashi, and M.E. Mendelsohn Synergistic activation of endothelial nitric oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex J. Biol. Chem 278 2003 30821 30827 (Pubitemid 36994590)
124. C.L. Stebbins, J.P. Stice, C.M. Hart, F.N. Mbai, and A.A. Knowlton Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells J. Cardiovasc. Pharmacol. Ther. 13 2008 261 268
125. 2 release modulates endothelial nitric-oxide synthase via extracellular signal-regulated kinase (ERK) 1/2-mediated serine 635 phosphorylation J. Biol. Chem. 286 2011 20100 20108
126. H. Xue, M. Wan, D. Song, Y. Li, and J. Li Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium Vasc. Pharmacol 44 2006 434 439 (Pubitemid 43766666)
127. B.J. Michell, Z. Chen, T. Tiganis, D. Stapleton, F. Katsis, D.A. Power, A.T. Sim, and B.E. Kemp Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase J. Biol. Chem. 276 2001 17625 17628
128. Z. Chen, I.C. Peng, W. Sun, M.I. Su, P.H. Hsu, Y. Fu, Y. Zhu, K. DeFea, S. Pan, M.D. Tsai, and J.Y. Shyy AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633 Circ. Res. 104 2009 496 505
129. S.D. Poppitt, C.A. Howe, F.E. Lithander, K.M. Silvers, R.B. Lin, J. Croft, Y. Ratnasabapathy, R.A. Gibson, and C.S. Anderson Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial Stroke 40 2009 3485 3492
130. N.J. Sjoberg, C.M. Milte, J.D. Buckley, P.R. Howe, A.M. Coates, and D.A. Saint Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation Br. J. Nutr. 103 2010 243 248
131. P. Galan, E. Kesse-Guyot, S. Czernichow, S. Briancon, J. Blacher, and S. Hercberg SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial BMJ 341 c6273 2010
132. A.C. Skulas-Ray, P.M. Kris-Etherton, W.S. Harris, J.P. Vanden Heuvel, P.R. Wagner, and S.G. West Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia Am. J. Clin. Nutr. 93 2011 243 252